Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | E2F6 |
| Upstream (Parents) |
|---|
| (<<) ATIC → E2F6 |
| (<<) CD3EAP → E2F6 |
| (<<) DDX18 → E2F6 |
| (<<) E2F5 → E2F6 |
| (<<) HRAS → E2F6 |
| (<<) HSPA8 → E2F6 |
| (<<) PRR7 → E2F6 |
| (<<) RPL35 → E2F6 |
| (<<) S100A2 → E2F6 |
| (<<) STX1A → E2F6 |
| (<<) TUBB2C → E2F6 |
| (<<) YWHAQ → E2F6 |
| Downstream (Children) |
|---|
| E2F6 → CCND1 (>>) |
| E2F6 → CCNE1 (>>) |
| E2F6 → CDK8 (>>) |
| E2F6 → EIF2C2 (>>) |
| E2F6 → EPHA2 (>>) |
| E2F6 → GNB1L (>>) |
| E2F6 → ODC1 (>>) |
| E2F6 → PAK1 (>>) |
| E2F6 → PNO1 (>>) |
| E2F6 → RPS6KB1 (>>) |
| E2F6 → RRP9 (>>) |
| E2F6 → TCEAL1 (>>) |
| E2F6 → VANGL1 (>>) |
